Cargando…

Molecular fingerprinting catches responders to therapeutic agents

High-dimensional -omics profiling predicts responses to therapeutic agents in breast cancer cell lines that can be effectively applied to patient selection in clinical trials.

Detalles Bibliográficos
Autores principales:	Malik, Simeen, Tan, Patrick, Ng, Pauline C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4056435/ https://www.ncbi.nlm.nih.gov/pubmed/24176101 http://dx.doi.org/10.1186/gb-2013-14-10-135

Ejemplares similares

A pan-cancer fingerprint: common molecular denominators of the human tumor microenvironment
por: Ng, Susanna S., et al.
Publicado: (2021)

Catching global interactions in vivo
por: Qiu, Yi, et al.
Publicado: (2017)

Catch-as-catch-can: mRNA vaccination boosts immune responses to SARS-CoV-2 variants
por: Pawelec, Graham, et al.
Publicado: (2021)

The greatest catch: big game fishing for mRNA-bound proteins
por: Sibley, Christopher R, et al.
Publicado: (2012)

Extracellular vesicle fingerprinting: the next generation for cancer diagnosis?
por: Sandim, Vanessa, et al.
Publicado: (2020)

Molecular Detection of Biological Agents in the Field: Then and Now
por: Yeh, Kenneth B., et al.
Publicado: (2019)

Dynamic mechanism of GPCR-mediated β-arrestin: a potential therapeutic agent discovery of biased drug
por: Xu, Zheng, et al.
Publicado: (2022)

Predicting cancer drivers: are we there yet?
por: Krishnan, Vidhya G, et al.
Publicado: (2012)

Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities
por: Ryan, Tristram A. J., et al.
Publicado: (2022)

Regulatory T cells as a therapeutic approach for inflammatory bowel disease
por: Laukova, Marcela, et al.
Publicado: (2023)

The anti-ferroptotic role of FSP1: current molecular mechanism and therapeutic approach
por: Zeng, Furong, et al.
Publicado: (2022)

Mucosal epithelial cells: the initial sentinels and responders controlling and regulating immune responses to viral infections
por: Yang, Jingyi, et al.
Publicado: (2021)

Prostaglandin regulation of type 2 inflammation: From basic biology to therapeutic interventions
por: Oyesola, Oyebola O., et al.
Publicado: (2021)

In search for novel strategies towards neuroprotection and neuroregeneration: is PPARα a promising therapeutic target?
por: Moreno, Sandra, et al.
Publicado: (2015)

Janus kinase signaling as risk factor and therapeutic target for severe SARS‐CoV‐2 infection
por: Solimani, Farzan, et al.
Publicado: (2021)

Targeting B cells and plasma cells in autoimmune diseases: From established treatments to novel therapeutic approaches
por: Merino‐Vico, Ana, et al.
Publicado: (2022)

Tools of the trade: plasmid repositories and standardized plasmid manipulation for molecular and synthetic biology
por: Dolan, Stephen K., et al.
Publicado: (2022)

Toward a molecular understanding of fluoride stress in a model Pseudomonas strain
por: Wackett, Lawrence P.
Publicado: (2022)

A promiscuous interaction of SARS-CoV-2 with bacterial products
por: Carissimo, Guillaume, et al.
Publicado: (2020)

Hydrogen sulfide controls peripheral nerve degeneration and regeneration: a novel therapeutic strategy for peripheral demyelinating disorders or nerve degenerative diseases
por: Jung, Junyang, et al.
Publicado: (2014)

WNK1, a molecular crowding sensor, links phase separation to cellular physiological stress
por: Lan, Tinghui, et al.
Publicado: (2023)

New molecular tools for enhancing methane production, explaining thermodynamically limited lifestyles and other important biotechnological issues
por: Daniels, Craig, et al.
Publicado: (2009)

New molecular techniques for pathogen analysis, in silico determination of RND efflux pump substrate specificity, shotgun proteomic monitoring of bioremediation and yeast bio‐applications
por: Michán, Carmen, et al.
Publicado: (2010)

Surrogate cytokine agonists: promising agents against COVID-19
por: Lin, Zemin, et al.
Publicado: (2022)

Bacillus-related Spore Formers: Attractive Agents for Plant Growth Promotion
por: Toyota, Koki
Publicado: (2015)

TET enzymes: double agents in the transposable element–host genome conflict
por: Gerdes, Patricia, et al.
Publicado: (2016)

What a Clinician Should Know About a Renal Replacement Membrane?
por: Honore, Patrick M., et al.
Publicado: (2018)

Identifying therapeutic targets for schizophrenia
por: Montague-Cardoso, Karli
Publicado: (2021)

Curse and blessing: upregulation of oncogenes upon treatment with hypomethylating agents in myelodysplastic syndrome
por: Grimm, Juliane, et al.
Publicado: (2022)

ASGR1: an emerging therapeutic target in hypercholesterolemia
por: Zhao, Wenqi, et al.
Publicado: (2023)

Genetic tracing of HCoV-19 for the re-emerging outbreak of COVID-19 in Beijing, China
por: Yang, Jing, et al.
Publicado: (2020)

Newly synthesized M(pro) inhibitors as potential oral anti-SARS-CoV-2 agents
por: Li, Lin, et al.
Publicado: (2021)

EphB2: potential therapeutic target for Alzheimer’s disease
Publicado: (2011)

Ramucirumab, another anti-angiogenic agent for metastatic colorectal cancer in second-line setting—its impact on clinical practice
por: Goel, Gaurav, et al.
Publicado: (2015)

Reversible mechanical control of molecular conformation
por: Bissette, Andrew J.
Publicado: (2020)

Engineered nucleus-free mesenchymal stem cells (MSCs) for the targeted delivery of therapeutics to disease site
por: Schwartz, Zander, et al.
Publicado: (2022)

Disrupting redox stabilizer: a novel therapeutic strategy for colorectal cancer
por: Trachootham, Dunyaporn, et al.
Publicado: (2019)

NLRP3 inflammasome as a novel therapeutic target for Alzheimer’s disease
por: Zhang, Yun, et al.
Publicado: (2020)

Microglial lactate metabolism as a potential therapeutic target for Alzheimer’s disease
por: Zhao, Yingjun, et al.
Publicado: (2022)

Identification of Graphene Dispersion Agents through Molecular Fingerprints
por: Goldie, Stuart J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_phj6vg9m2u7cspjicb7jt5bj2j